Crucially, it inhibited CD8+ T cell apoptosis via the ERK/AP1 pathway.<h4>Discussion</h4>These findings provide mechanistic insights for developing Plantaricin BM-1 as an anti-CRC agent. This evidence concerns the gene CD8A and colorectal carcinoma.